A third set of six sheep was selected for determination of the possible effects of sildenafil on the AH protein levels of the AC. The protocol was designed so that AH was sampled from each eye only once. For this, AH was sampled from one eye and sildenafil was then administered, followed 80 minutes later by the sampling of AH from the second eye. IOP was also monitored during this protocol. As such, at
t = 0 of the experiment, baseline IOP was recorded in all eyes (
n = 12), and six samples of AH were withdrawn, with three right and three left eyes sampled (
Table 3). Thereafter, 100 mg of sildenafil was administered orally, and IOP was remeasured 80 minutes after drug ingestion. At this point, IOP was 20.8 ± 0.6 mm Hg, a value ∼2.2-fold higher than baseline (9.5 ± 0.1 mm Hg;
Table 3), and the IOPs of the eyes from which AH had already been sampled tended to be lower than that in the paired fellow eyes not yet exposed to the invasive protocol (19.8 ± 1.0 vs. 21.8 ± 0.6 mm Hg;
P < 0.02, paired data).
Table 3 shows the individual IOPs from the paired eyes at
t = 80 minutes. Paracentesis was then performed on the second eye of each sheep. The protein content from this sampling of AH was 0.122 ± 0.023 μg/μL, which was on average 60% higher than the value obtained from the contralateral eye sampled before sildenafil ingestion (0.076 ± 0.013 μg/μL;
P < 0.04, paired data;
Table 3). No other drugs or doses were tested on this parameter.
However, the paired statistical comparison presumes that AH protein concentrations in any one animal are equal in both eyes. Although this may be likely in principle, in practice, more or less protein may be withdrawn from a given eye by paracentesis, especially since there may be a gradient of protein from the angle to the front of the pupil.
3 As such, an unpaired comparison between the protein levels of the fellow eyes is more appropriate. Applying this analysis to the protein data in
Table 3 results in
P = 0.112 for the unpaired two-tailed data. Because we also had additional control data on the AH protein levels that were obtained from one eye of other sheep used for another study, we also compared this set of expanded control values with those from the six eyes of the sildenafil-treated animals shown in
Table 3. This group comparison is shown in
Table 4 and indicates that the mean level in 20 control eyes was significantly less (at the 5% level) than the mean in the six sildenafil-treated eyes. In this group comparison, the sildenafil-treated values are, on average, approximately 39% higher than the control levels. Overall, the tendency for there to be higher protein concentrations in the AH withdrawn from animals treated with sildenafil is consistent with an increased flow of plasmalike fluid into the AC with the associated diffusion of protein after administration of the vasodilator.